Essential medicines lists are for high income countries too

被引:6
作者
Brhlikova, Petra
Persaud, Nav [2 ]
Osorio-de-Castro, Claudia Garcia Serpa [3 ]
Pollock, Allyson M. [1 ]
机构
[1] Newcastle Univ, Populat Hlth Sci Inst, Newcastle Upon Tyne, England
[2] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada
[3] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Dept Polit Medicamentos & Assistencia Farmaceut, Rio De Janeiro, Brazil
来源
BMJ-BRITISH MEDICAL JOURNAL | 2023年 / 382卷
关键词
D O I
10.1136/bmj-2023-076783
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:2
相关论文
共 18 条
[1]  
Aitken M, 2020, Medicine spending and affordability in the U.S. 2020
[2]  
[Anonymous], 2011, The world medicines situation 2011: selection of essential medicines
[3]  
[Anonymous], Universal Health Coverage (UHC)
[4]   Essential medicines concept and health technology assessment approaches to prioritising medicines: selection versus incorporation [J].
Brhlikova, Petra ;
Deivanayagam, Thilagawathi Abi ;
Babar, Zaheer-Ud-Din ;
Osorio-de-Castro, Claudia Garcia Serpa ;
Caetano, Rosangela ;
Pollock, Allyson M. .
JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2023, 16 (01)
[5]   High adherence to the 'Wise List' treatment recommendations in Stockholm: a 15-year retrospective review of a multifaceted approach promoting rational use of medicines [J].
Eriksen, Jaran ;
Gustafsson, Lars L. ;
Ateva, Kristina ;
Bastholm-Rahmner, Pia ;
Ovesjo, Marie-Louise ;
Jirlow, Malena ;
Juhasz-Haverinen, Maria ;
Larfars, Gerd ;
Malmstrom, Rickard E. ;
Wettermark, Bjorn ;
Andersen-Karlsson, Eva .
BMJ OPEN, 2017, 7 (04)
[6]   Making medicines essential: The emergent centrality of pharmaceuticals in global health [J].
Greene, Jeremy A. .
BIOSOCIETIES, 2011, 6 (01) :10-33
[7]   Less Is More: Norwegian Drug Regulation, Antibiotic Policy, and the "Need Clause" [J].
Hobaek, Bard ;
Lie, Anne Kveim .
MILBANK QUARTERLY, 2019, 97 (03) :762-795
[8]   The concept of essential medicines: lessons for rich countries [J].
Hogerzeil, HV .
BRITISH MEDICAL JOURNAL, 2004, 329 (7475) :1169-1172
[9]   Pharmaceutical research and development: what do we get for all that money? [J].
Light, Donald W. ;
Lexchin, Joel R. .
BMJ-BRITISH MEDICAL JOURNAL, 2012, 345
[10]   Knowledge support for environmental information on pharmaceuticals: experiences among Swedish Drug and Therapeutics Committees [J].
Linder, Elkanah ;
Wettermark, Bjorn ;
Ovesjo, Marie-Louise ;
Sporrong, Sofia Kalvemark ;
Ramstrom, Helena .
BMC HEALTH SERVICES RESEARCH, 2023, 23 (01)